Stock Analysts’ price target changes for Tuesday, April 7th:
Arch Capital Group (NASDAQ:ACGL) had its target price boosted by Keefe, Bruyette & Woods from $104.00 to $105.00. Keefe, Bruyette & Woods currently has a market perform rating on the stock.
American Integrity Insurance Group (NYSE:AII) had its price target cut by Keefe, Bruyette & Woods from $28.00 to $27.00. Keefe, Bruyette & Woods currently has an outperform rating on the stock.
Ameriprise Financial (NYSE:AMP) had its price target reduced by Piper Sandler from $530.00 to $460.00. The firm currently has a neutral rating on the stock.
AON (NYSE:AON) had its target price reduced by Keefe, Bruyette & Woods from $416.00 to $401.00. The firm currently has an outperform rating on the stock.
Artisan Partners Asset Management (NYSE:APAM) had its price target lowered by The Goldman Sachs Group, Inc. from $39.00 to $34.00. The Goldman Sachs Group, Inc. currently has a sell rating on the stock.
Apollo Global Management (NYSE:APO) had its price target trimmed by The Goldman Sachs Group, Inc. from $169.00 to $134.00. The firm currently has a buy rating on the stock.
Ares Management (NYSE:ARES) had its target price reduced by The Goldman Sachs Group, Inc. from $165.00 to $131.00. The firm currently has a buy rating on the stock.
Axis Capital (NYSE:AXS) had its price target cut by Keefe, Bruyette & Woods from $130.00 to $126.00. The firm currently has an outperform rating on the stock.
Brookfield Asset Management (NYSE:BAM) (TSE:BAM.A) had its target price lowered by The Goldman Sachs Group, Inc. from $60.00 to $49.00. They currently have a buy rating on the stock.
BCE (TSE:BCE) (NYSE:BCE) had its target price cut by Desjardins from C$42.00 to C$41.50. The firm currently has a buy rating on the stock.
Bayhorse Silver (CVE:BHS) was given a C$0.21 price target by analysts at Fundamental Research. The firm currently has a buy rating on the stock.
Bowhead Specialty (NYSE:BOW) had its price target reduced by Keefe, Bruyette & Woods from $36.00 to $31.00. They currently have an outperform rating on the stock.
Popular (NASDAQ:BPOP) had its target price raised by Barclays PLC from $175.00 to $180.00. Barclays PLC currently has an overweight rating on the stock.
Brown & Brown (NYSE:BRO) had its target price increased by Keefe, Bruyette & Woods from $73.00 to $74.00. They currently have a market perform rating on the stock.
Boston Scientific (NYSE:BSX) had its price target trimmed by Citigroup Inc. from $94.00 to $87.00. Citigroup Inc. currently has a buy rating on the stock.
Baldwin Insurance Group (NASDAQ:BWIN) had its target price cut by Keefe, Bruyette & Woods from $29.00 to $26.00. Keefe, Bruyette & Woods currently has an outperform rating on the stock.
Boyd Group Services (TSE:BYD) had its price target lowered by Canadian Imperial Bank of Commerce from C$280.00 to C$275.00.
Cogeco Communications (TSE:CCA) had its price target cut by Desjardins from C$72.00 to C$71.00. Desjardins currently has a hold rating on the stock.
Carlyle Group (NASDAQ:CG) had its price target reduced by The Goldman Sachs Group, Inc. from $81.00 to $69.00. The Goldman Sachs Group, Inc. currently has a buy rating on the stock.
Church & Dwight (NYSE:CHD) had its target price lowered by UBS Group AG from $102.00 to $98.00. They currently have a neutral rating on the stock.
Cincinnati Financial (NASDAQ:CINF) had its price target cut by Keefe, Bruyette & Woods from $191.00 to $190.00. They currently have an outperform rating on the stock.
Colgate-Palmolive (NYSE:CL) had its target price trimmed by UBS Group AG from $100.00 to $98.00. The firm currently has a buy rating on the stock.
Clorox (NYSE:CLX) had its price target reduced by UBS Group AG from $121.00 to $110.00. UBS Group AG currently has a neutral rating on the stock.
Canadian National Railway (NYSE:CNI) (TSE:CNR) had its target price increased by Citigroup Inc. from $115.00 to $123.00. They currently have a buy rating on the stock.
Canadian Natural Resources (TSE:CNQ) (NYSE:CNQ) had its target price raised by JPMorgan Chase & Co. from C$48.00 to C$70.00.
Canadian National Railway (TSE:CNR) (NYSE:CNI) had its price target raised by JPMorgan Chase & Co. from C$147.00 to C$153.00.
Canadian Pacific Kansas City (NYSE:CP) (TSE:CP) had its target price raised by Citigroup Inc. from $86.00 to $93.00. They currently have a buy rating on the stock.
Cognizant Technology Solutions (NASDAQ:CTSH) had its price target cut by Citigroup Inc. from $86.00 to $68.00. Citigroup Inc. currently has a neutral rating on the stock.
Cadrenal Therapeutics (NASDAQ:CVKD) had its target price cut by HC Wainwright from $32.00 to $13.00. The firm currently has a buy rating on the stock.
Donegal Group (NASDAQ:DGICA) had its price target lowered by Keefe, Bruyette & Woods from $19.50 to $19.00. The firm currently has a market perform rating on the stock.
Domino’s Pizza (NASDAQ:DPZ) had its target price cut by Citigroup Inc. from $440.00 to $425.00. Citigroup Inc. currently has a neutral rating on the stock.
Everest Group (NYSE:EG) had its target price lowered by Keefe, Bruyette & Woods from $430.00 to $402.00. The firm currently has an outperform rating on the stock.
Estee Lauder Companies (NYSE:EL) had its price target cut by UBS Group AG from $107.00 to $75.00. They currently have a neutral rating on the stock.
e.l.f. Beauty (NYSE:ELF) had its target price lowered by UBS Group AG from $102.00 to $70.00. The firm currently has a neutral rating on the stock.
Enbridge (TSE:ENB) (NYSE:ENB) had its target price raised by Barclays PLC from C$68.00 to C$73.00.
Energizer (NYSE:ENR) had its target price trimmed by UBS Group AG from $25.00 to $17.00. The firm currently has a neutral rating on the stock.
Oceanic Iron Ore (CVE:FEO) was given a C$2.00 target price by analysts at Haywood Securities. The firm currently has a buy rating on the stock.
Goosehead Insurance (NASDAQ:GSHD) had its target price lowered by Keefe, Bruyette & Woods from $85.00 to $75.00. They currently have an outperform rating on the stock.
Helen of Troy (NASDAQ:HELE) had its price target trimmed by UBS Group AG from $22.00 to $16.00. They currently have a neutral rating on the stock.
Hippo (NYSE:HIPO) had its price target reduced by Keefe, Bruyette & Woods from $33.00 to $30.00. The firm currently has a market perform rating on the stock.
Hammond Power Solutions (TSE:HPS.A) had its price target boosted by National Bank Financial from C$220.00 to C$235.00. They currently have an outperform rating on the stock.
Invesco (NYSE:IVZ) had its target price trimmed by The Goldman Sachs Group, Inc. from $30.00 to $27.00. The firm currently has a neutral rating on the stock.
KKR & Co. Inc. (NYSE:KKR) had its price target lowered by The Goldman Sachs Group, Inc. from $145.00 to $110.00. They currently have a buy rating on the stock.
Kenvue (NYSE:KVUE) had its target price reduced by UBS Group AG from $19.00 to $18.00. They currently have a neutral rating on the stock.
MediaAlpha (NYSE:MAX) had its price target trimmed by Keefe, Bruyette & Woods from $16.00 to $15.00. The firm currently has an outperform rating on the stock.
Mosaic (NYSE:MOS) was given a $28.00 target price by analysts at Royal Bank Of Canada. The firm currently has a sector perform rating on the stock.
Marsh & McLennan Companies (NYSE:MRSH) had its price target trimmed by Keefe, Bruyette & Woods from $206.00 to $200.00. The firm currently has a market perform rating on the stock.
Marsh & McLennan Companies (NYSE:MRSH) had its price target reduced by Keefe, Bruyette & Woods from $206.00 to $200.00. They currently have a market perform rating on the stock.
Neurocrine Biosciences (NASDAQ:NBIX) had its target price increased by Citigroup Inc. from $204.00 to $242.00. The firm currently has a buy rating on the stock.
Neptune Insurance (NYSE:NP) had its price target raised by Keefe, Bruyette & Woods from $25.00 to $28.00. They currently have an outperform rating on the stock.
Nutrien (NYSE:NTR) had its target price boosted by Royal Bank Of Canada from $80.00 to $85.00. The firm currently has an outperform rating on the stock.
North West (TSE:NWC) had its target price boosted by Royal Bank Of Canada from C$58.00 to C$60.00. The firm currently has an outperform rating on the stock.
Old National Bancorp (NASDAQ:ONB) had its price target boosted by Barclays PLC from $29.00 to $30.00. They currently have an overweight rating on the stock.
Oruka Therapeutics (NASDAQ:ORKA) had its target price raised by Barclays PLC from $50.00 to $78.00. They currently have an overweight rating on the stock.
Blue Owl Capital (NYSE:OWL) had its price target trimmed by The Goldman Sachs Group, Inc. from $14.00 to $9.00. They currently have a neutral rating on the stock.
Progressive (NYSE:PGR) had its target price lowered by Keefe, Bruyette & Woods from $227.00 to $210.00. The firm currently has a market perform rating on the stock.
Palomar (NASDAQ:PLMR) had its price target boosted by Keefe, Bruyette & Woods from $183.00 to $186.00. The firm currently has an outperform rating on the stock.
Pinnacle Financial Partners (NYSE:PNFP) had its price target lowered by Barclays PLC from $135.00 to $130.00. They currently have an overweight rating on the stock.
Quebecor (TSE:QBR.B) had its target price increased by Canadian Imperial Bank of Commerce from C$61.00 to C$66.00.
Quebecor (TSE:QBR.B) was given a C$61.00 price target by analysts at Desjardins. The firm currently has a buy rating on the stock.
Rogers Communications (TSE:RCI.B) (NYSE:RCI) had its price target lowered by Desjardins from C$55.00 to C$54.50. The firm currently has a hold rating on the stock.
Rogers Communications (TSE:RCI.B) (NYSE:RCI) had its price target trimmed by Canaccord Genuity Group Inc. from C$57.00 to C$55.50. The firm currently has a buy rating on the stock.
RH (NYSE:RH) had its target price cut by The Goldman Sachs Group, Inc. from $101.00 to $88.00. They currently have a sell rating on the stock.
RLI (NYSE:RLI) had its price target lowered by Keefe, Bruyette & Woods from $70.00 to $67.00. They currently have an outperform rating on the stock.
RenaissanceRe (NYSE:RNR) had its target price increased by Keefe, Bruyette & Woods from $323.00 to $327.00. They currently have a market perform rating on the stock.
Root (NASDAQ:ROOT) had its target price trimmed by Keefe, Bruyette & Woods from $104.00 to $95.00. The firm currently has an outperform rating on the stock.
Ryan Specialty (NYSE:RYAN) had its target price lowered by Keefe, Bruyette & Woods from $55.00 to $49.00. They currently have an outperform rating on the stock.
Selective Insurance Group (NASDAQ:SIGI) had its target price lowered by Keefe, Bruyette & Woods from $92.00 to $84.00. The firm currently has a market perform rating on the stock.
Skyward Specialty Insurance Group (NASDAQ:SKWD) had its target price lowered by Keefe, Bruyette & Woods from $70.00 to $65.00. Keefe, Bruyette & Woods currently has an outperform rating on the stock.
Stryker (NYSE:SYK) had its target price lowered by Citigroup Inc. from $420.00 to $385.00. Citigroup Inc. currently has a buy rating on the stock.
Sysco (NYSE:SYY) had its price target reduced by Piper Sandler from $83.00 to $77.00. They currently have a neutral rating on the stock.
TELUS (TSE:T) (NYSE:TU) had its target price cut by Desjardins from C$23.00 to C$21.50. They currently have a buy rating on the stock.
Transcontinental (TSE:TCL.A) had its target price cut by ATB Cormark Capital Markets from C$27.00 to C$7.00. ATB Cormark Capital Markets currently has an outperform rating on the stock.
TFI International (TSE:TFII) had its price target boosted by Citigroup Inc. from C$143.00 to C$144.00. They currently have a buy rating on the stock.
Toromont Industries (TSE:TIH) had its target price raised by BMO Capital Markets from C$210.00 to C$215.00.
TPG (NASDAQ:TPG) had its price target lowered by The Goldman Sachs Group, Inc. from $80.00 to $55.00. They currently have a buy rating on the stock.
Targa Resources (NYSE:TRGP) had its price target raised by Barclays PLC from $226.00 to $255.00. Barclays PLC currently has an overweight rating on the stock.
TWFG (NASDAQ:TWFG) had its target price reduced by Keefe, Bruyette & Woods from $31.00 to $25.00. Keefe, Bruyette & Woods currently has a market perform rating on the stock.
10x Genomics (NASDAQ:TXG) had its price target increased by Citigroup Inc. from $18.00 to $24.00. They currently have a neutral rating on the stock.
Viridian Therapeutics (NASDAQ:VRDN) had its price target trimmed by The Goldman Sachs Group, Inc. from $36.00 to $31.00. They currently have a buy rating on the stock.
Western Alliance Bancorporation (NYSE:WAL) had its price target cut by Barclays PLC from $90.00 to $88.00. They currently have an overweight rating on the stock.
Willis Towers Watson Public (NASDAQ:WTW) had its price target reduced by Keefe, Bruyette & Woods from $388.00 to $384.00. Keefe, Bruyette & Woods currently has an outperform rating on the stock.
Receive News & Ratings for Arch Capital Group Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Capital Group Ltd and related companies with MarketBeat.com's FREE daily email newsletter.
